Netherlands· NL-9b6af99671f5

Truxal 50 mg filmomhulde tabletten, filmomhulde tabletten

A chlorprothixene product containing chloorprothixeenhydrochloride, registered in Netherlands by Lundbeck B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC N05AF03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about chloorprothixeenhydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Chlorprothixene is registered in 10 of 19 countries.

Countries holding a registration under ATC N05AF03 (chlorprothixene), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search chlorprothixene products by name

Chlorprothixene · ATC N05AF03

10 / 19 countries

Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of chlorprothixene costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Chlorprothixene · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

CH Switzerland$3.86

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: CHLOORPROTHIXEENHYDROCHLORIDE
Manufacturer: Lundbeck B.V.
Country: Netherlands (NL)
ATC code: N05AF03
ATC class: Chlorprothixene
Defined daily dose: 0.3 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
04299

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

27 interactions on record for chlorprothixene.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check chlorprothixene against other medicines How interaction checks work

Chlorprothixene · interactions on record

27 records

27 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Chlorprothixene in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorprothixene products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

Austria · Truxal
Bulgaria · Хлорпротиксен 15 Зентива
Czechia · Chlorprothixen Léčiva
Germany · Chlorprothixen Holsten, Chlorprothixen Neuraxpharm
Denmark · Truxal
Estonia · Truxal
Finland · Truxal
Hungary · Truxal
Iceland · Truxal
Lithuania · Truxal
Latvia · Truxal
Norway · Truxal
Poland · Chlorprothixen Hasco, Chlorprothixen Zentiva
Sweden · Truxal
Slovakia · Chlorprothixen Léčiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/2ceefb35-a30f-43ad-9eaf-9793aca2fa53
GET /v1/drugs/2ceefb35-a30f-43ad-9eaf-9793aca2fa53?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h04299_smpc.pdf",
  "strength": null,
  "atc_label": "Chlorprothixene",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg04299",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "COPOVIDON (E 1208)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GLYCEROL 85 PER CENT (E 422)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "CHLOORPROTHIXEENHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h04299.pdf",
  "authorised_at": "1990/05/20",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "04299",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about chlorprothixene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console